Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEMAT-FMT: Fecal Microbiota Transplantation in Adult Patients With Malignant Hematological Diseases
NCT07172191Enrolling by invitation
- Start
- Oct 2025
- Primary completion
- Dec 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label trial of fecal microbiome transplant in hematologic malignancy (2 arms). Primary endpoint: Disease activity at Day 180. Started Oct 2025; status: enrolling by invitation.
02
Drugs
fecal microbiome transplant
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT07172191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07172191.